Explorer les evidences

1 112 casesBetween 2008 and 2013, 1,112 cases with a new diagnosis of prostate cancer were enrolled in the MCC-Spain study.

Burkina Fasocancer de la prostateobservé 2008-2013publié 2015Gaceta sanitariaeurope_pmcdocument de 9 observations

409 000 deathsMalaria caused 409,000 deaths worldwide in 2019.

Burkina Fasopaludismeobservé 2019HAL · Unilimdocument de 110 observations

Anopheles gambiae s.s. is the most frequent malaria vector in Guinea Bissau.

Burkina Fasopaludismeobservé 2002publié 2008Bulletin de la Societe de pathologie exotique (1990)europe_pmcdocument de 6 observations

27 %A phase 3 clinical trial of RTS,S/AS01 across eleven sub-Saharan African sites demonstrated a vaccine efficacy against clinical malaria of ~27% in infants aged 6–12 weeks.

Burkina FasopaludismeHAL · Unilimdocument de 39 observations

55 %In the rainy season, the RDT specificity for malaria-attributable fever was 55% in Burkina Faso.

Burkina Fasopaludismeobservé rainy seasonpublié 2010Malaria journaleurope_pmcdocument de 20 observationsDOI 10.1186/1475-2875-9-192

1,51 odds_ratioEarly sexual activity is associated with increased odds of HIV seropositivity in young women (OR = 1.510; 95% CI = 1.100, 2.072).

Burkina FasoVIH/sidapublié 2021Journal of global healthPubMeddocument de 4 observations

37 %In the rainy season, 623 out of 1,669 patients without fever (37%) had a Plasmodium falciparum infection in Burkina Faso.

Burkina Fasopaludismeobservé rainy seasonpublié 2010Malaria journaleurope_pmcdocument de 20 observationsDOI 10.1186/1475-2875-9-192

3 %The test threshold was 3%.

Burkina Fasopaludismepublié 2013PloS oneeurope_pmcdocument de 6 observations

1,38 %In Sector 6, the severe malaria morbidity rate among people over 5 years of age was 1.38% in 2023.

Burkina Fasopaludismeobservé 2023HAL · Unilimdocument de 110 observations

14 %Washed alpha-cypermethrin-treated nets provided 14% personal protection against Anopheles gambiae s.l. biting.

Burkina Fasopaludismepublié 2017Malaria journaleurope_pmcdocument de 6 observations

0,543 rAt D70, there was a positive correlation between anti-major repeat IgG and anti-full-length PfCSP4/38 IgG (r = 0.5430, P = 0.0134).

Burkina FasopaludismeHAL · Unilimdocument de 39 observations

5,8 odds_ratioActive placental malaria was associated with childhood parasitaemia (OR 5.8; 95% CI 1.0–32.5, P = 0.042).

Burkina Fasopaludismepublié 2021Maternal & child nutritioneurope_pmcdocument de 11 observations

8 patientsRescue therapy was required in all teenaged malaria patients (8/8) receiving SAR97276A once daily (0.5 mg/kg) for 3 days.

Burkina Fasopaludismepublié 2017Malaria journaleurope_pmcdocument de 5 observationsDOI 10.1186/s12936-017-1832-x

12,2 %The dhfr N51I mutation was present in 12.2% of 255 successfully genotyped samples from pregnant women in Nanoro, Burkina Faso.

Burkina Fasopaludismeobservé 2010publié 2015PloS oneeurope_pmcdocument de 8 observations

51 %In Burkina Faso, a quasi-experimental study in Kaya district showed a 51% reduction in malaria risk, a 32% decrease in moderate/severe anemia, and a 46% drop in febrile episodes.

Burkina FasopaludismeHAL · Unilimdocument de 147 observations

51 %La prévalence de l'infection à Plasmodium falciparum était de 51 % (1513/2950) dans le groupe LLIN seul au Burkina Faso après intervention.

Burkina FasopaludismeHAL · Unilimdocument de 85 observations

3,06 ratioNLR was elevated in those with high parasitaemia (3.06 vs 2.55; p=0.029).

Burkina Fasopaludismepublié 2026Transactions of the Royal Society of Tropical Medicine and Hygieneeurope_pmcdocument de 6 observations

1 122 episodesNonmalarial febrile illnesses occurred in 1122 episodes in the azithromycin group and 1424 episodes in the placebo group.

Burkina Faso · Malinonmalarial febrile illnessespublié 2019The New England journal of medicineeurope_pmcdocument de 4 observations

56,5 %For multigravidae, a prediction model using IL-10 and sTNF-RII had a sensitivity of 56.5% and specificity of 94.3% for diagnosing malaria during pregnancy.

Burkina Fasopaludismepublié 2017Biomarker researcheurope_pmcdocument de 5 observations

14 %The most common adverse event was worsening malaria in cohort 2, occurring in 23 (14%) of 164 patients.

Burkina Fasopaludismepublié 2015The Lancet. Infectious diseaseseurope_pmcdocument de 10 observations

0,35 %From 2006 to 2008, the confirmed yellow fever case proportion in Burkina Faso was respectively 0.35%, 0.27%, and 0.54%.

Burkina Fasofièvre jauneobservé 2006publié 2010Bulletin de la Societe de pathologie exotique (1990)europe_pmcdocument de 5 observations

4 %In children who received RTS,S/AS01E vaccine in Burkina Faso and Mali, 4% showed a 10-fold increase in anti-CSP IgG antibody titres post-2020 as measured by Oxford MSD assay.

Burkina Faso · Malipaludismeobservé post-2020HAL · Unilimdocument de 105 observations

0,21 p-valueNo significant differences in neonatal mortality were found between treatment arms (p = 0.21).

Burkina Fasomortalité néonatalepublié 2019Malaria journaleurope_pmcdocument de 6 observations

78,3 %Isolated fever had sensitivity of 78.3% and specificity of 71.3% for malaria diagnosis.

Burkina FasopaludismeHAL · Unilimdocument de 83 observations

33,4 %In the per-protocol group of 4577 RTS,S/AS01-vaccinated participants and 2335 control-vaccinated participants who were 5 to 17 months of age, the 1-year cumulative vaccine efficacy was 33.4% against mismatched clinical malaria.

Burkina Fasopaludismepublié 2015The New England journal of medicineeurope_pmcdocument de 5 observationsDOI 10.1056/nejmoa1505819